^
Association details:
Biomarker:FGF19 expression
Cancer:Ovarian Cancer
Drug:fexagratinib (ABSK091) (FGFR inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

THE ANTI-CANCER EFFECTS OF AZD4547 ON OVARIAN CANCER CELLS: DIFFERENTIAL RESPONSES BASED ON FGF19 AND C-MET EXPRESSIONS

Published date:
10/18/2023
Excerpt:
AZD4547 significantly decreased tumor weight in xenograft models of EOC...We suggest that expression level of c-Met or FGF19 can be a predictive biomarker for AZD4547 treatment...